IBDEI0VA ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15430,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15430,1,4,0)
 ;;=4^307.41
 ;;^UTILITY(U,$J,358.3,15430,1,5,0)
 ;;=5^Insomnia, Nonorganic, Transient
 ;;^UTILITY(U,$J,358.3,15430,2)
 ;;=^268285
 ;;^UTILITY(U,$J,358.3,15431,0)
 ;;=780.52^^89^907^100
 ;;^UTILITY(U,$J,358.3,15431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15431,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,15431,1,5,0)
 ;;=5^Insomnia, Organic
 ;;^UTILITY(U,$J,358.3,15431,2)
 ;;=Insomnia, Organic^87662
 ;;^UTILITY(U,$J,358.3,15432,0)
 ;;=302.71^^89^907^103
 ;;^UTILITY(U,$J,358.3,15432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15432,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,15432,1,5,0)
 ;;=5^Loss of Libido
 ;;^UTILITY(U,$J,358.3,15432,2)
 ;;=^268178
 ;;^UTILITY(U,$J,358.3,15433,0)
 ;;=785.6^^89^907^106
 ;;^UTILITY(U,$J,358.3,15433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15433,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,15433,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,15433,2)
 ;;=Lymphadenopathy^72368
 ;;^UTILITY(U,$J,358.3,15434,0)
 ;;=728.85^^89^907^112
 ;;^UTILITY(U,$J,358.3,15434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15434,1,4,0)
 ;;=4^728.85
 ;;^UTILITY(U,$J,358.3,15434,1,5,0)
 ;;=5^Muscle Spasm
 ;;^UTILITY(U,$J,358.3,15434,2)
 ;;=Muscle Spasm^112558
 ;;^UTILITY(U,$J,358.3,15435,0)
 ;;=782.0^^89^907^51
 ;;^UTILITY(U,$J,358.3,15435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15435,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,15435,1,5,0)
 ;;=5^Disturbance of Skin Sensation
 ;;^UTILITY(U,$J,358.3,15435,2)
 ;;=Disturbance of Skin Sensation^35757
 ;;^UTILITY(U,$J,358.3,15436,0)
 ;;=278.00^^89^907^117
 ;;^UTILITY(U,$J,358.3,15436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15436,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,15436,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,15436,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,15437,0)
 ;;=278.01^^89^907^118
 ;;^UTILITY(U,$J,358.3,15437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15437,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,15437,1,5,0)
 ;;=5^Obesity, Morbid
 ;;^UTILITY(U,$J,358.3,15437,2)
 ;;=Obesity, Morbid^84844
 ;;^UTILITY(U,$J,358.3,15438,0)
 ;;=783.5^^89^907^127
 ;;^UTILITY(U,$J,358.3,15438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15438,1,4,0)
 ;;=4^783.5
 ;;^UTILITY(U,$J,358.3,15438,1,5,0)
 ;;=5^Polydipsia
 ;;^UTILITY(U,$J,358.3,15438,2)
 ;;=Polydipsia^186699
 ;;^UTILITY(U,$J,358.3,15439,0)
 ;;=783.6^^89^907^128
 ;;^UTILITY(U,$J,358.3,15439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15439,1,4,0)
 ;;=4^783.6
 ;;^UTILITY(U,$J,358.3,15439,1,5,0)
 ;;=5^Polyphagia
 ;;^UTILITY(U,$J,358.3,15439,2)
 ;;=Polyphagia^60236
 ;;^UTILITY(U,$J,358.3,15440,0)
 ;;=780.2^^89^907^144
 ;;^UTILITY(U,$J,358.3,15440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15440,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,15440,1,5,0)
 ;;=5^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,15440,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,15441,0)
 ;;=783.1^^89^907^156
 ;;^UTILITY(U,$J,358.3,15441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15441,1,4,0)
 ;;=4^783.1
 ;;^UTILITY(U,$J,358.3,15441,1,5,0)
 ;;=5^Weight gain, abnormal
 ;;^UTILITY(U,$J,358.3,15441,2)
 ;;=^998
 ;;^UTILITY(U,$J,358.3,15442,0)
 ;;=783.21^^89^907^157
 ;;^UTILITY(U,$J,358.3,15442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15442,1,4,0)
 ;;=4^783.21
 ;;^UTILITY(U,$J,358.3,15442,1,5,0)
 ;;=5^Weight loss, abnormal
 ;;^UTILITY(U,$J,358.3,15442,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,15443,0)
 ;;=796.2^^89^907^32
 ;;^UTILITY(U,$J,358.3,15443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15443,1,4,0)
 ;;=4^796.2
